Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2018;392(10159):1736-88.

Zhao D. Epidemiological Features of Cardiovascular Disease in Asia. JACC Asia. 2021;1(1):1-13.

Khan MA, Hashim MJ, Mustafa H, Baniyas MY, Al Suwaidi S, AlKatheeri R, et al. Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study. Cureus. 2020;12(7):e9349.

Wang XY, Zhang F, Zhang C, Zheng LR, Yang J. The Biomarkers for Acute Myocardial Infarction and Heart Failure. Biomed Res Int. 2020;2020:2018035.

Chen Y, Tao Y, Zhang L, Xu W, Zhou X. Diagnostic and prognostic value of biomarkers in acute myocardial infarction. Postgrad Med J. 2019;95(1122):210-6.

Fang L, Moore XL, Dart AM, Wang LM. Systemic inflammatory response following acute myocardial infarction. J Geriatr Cardiol. 2015;12(3):305-12.

Seropian IM, Sonnino C, Van Tassell BW, Biasucci LM, Abbate A. Inflammatory markers in ST-elevation acute myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2016;5(4):382-95.

Hirschson Prado A, Higa C, Merlo P, Domine E, Blanco P, Vazquez G. Prognostic Value of the leuko-glycemic Index in Acute Myocardial Infarction. results from the SCAr Multicenter registry. Rev Argent Cardiol. 2014;82(6):500-5.

Quiroga W, Conci E, Zelaya F, Isa M, Pacheco G, Sala J. [Estratificación del riesgo en el infarto agudo de miocardio según el índice leucoglucémico.¿ El Killip-Kimball de laboratorio]. Rev Fed Arg Cardiol. 2010;39(1):29-34. Spanish.

Chermiti I, Ghazal H, Dimassi R, Mahdhoui S, Gnena H, Chiboub S, et al. Prognostic Value of Leuko-glycemic Index in ST Segment Elevation Myocardial Infarction. JEM. 2017;53(3):435.

Cañas ESV, Sanchez MMH, Olalde JAG, de Sarachaga AJ, Rodríguez ALB, Mas RNM, et al. Neutrophil-lymphocyte and leuko-glycemic indices as predictive markers for ventilatory support in patients with Guillain-Barre syndrome. Arch Neurocien [Internet]. 2023;28(2) (Jan. 2023)

León-Aliz E, Moreno-Martínez FL, Pérez-Fernández GA, Vega-Fleites LF, Rabassa-López-Calleja MA. [Leuko-glycemic index as an in-hospital prognostic marker in patients with ST-segment elevation myocardial infarction]. Clin Investig Arterioscler. 2014;26(4):168-75. Spanish.

Seoane LA, Burgos L, Espinoza JC, Furmento JF, Benzadón MN, Vrancic JM, et al. Prognostic Value of the Leuko-Glycaemic Index in the Postoperative Period of Coronary Artery Bypass Grafting. Braz J Cardiovasc Surg. 2021;36(4):484-91.

Sadeghi R, Dizaji SR, Vazirizadeh-Mahabadi M, Sarveazad A, Forouzannia SA. Prognostic Value of The Leuko-Glycemic Index in Acute Myocardial Infarction; a Systematic Review and Meta-Analysis. AAEM. 2023;11(1):e25

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). Circulation. 2018;138(20):e618-e51.

Qi LY, Liu HX, Cheng LC, Luo Y, Yang SQ, Chen X, et al. Prognostic Value of the Leuko-Glycemic Index in Acute Myocardial Infarction Patients with or without Diabetes. Diabetes Metab Syndr Obes. 2022;15:1725-36.

Barron HV, Harr SD, Radford MJ, Wang Y, Krumholz HM. The association between white blood cell count and acute myocardial infarction mortality in patients > or =65 years of age: findings from the cooperative cardiovascular project. J Am Coll Cardiol. 2001;38(6):1654-61.

Meissner J, Irfan A, Twerenbold R, Mueller S, Reiter M, Haaf P, et al. Use of neutrophil count in early diagnosis and risk stratification of AMI. Am J Med. 2011;124(6):534-42.

Deckers JW, van Domburg RT, Akkerhuis M, Nauta ST. Relation of admission glucose levels, short- and long-term (20-year) mortality after acute myocardial infarction. Am J Cardiol. 2013;112(9):1306-10.

Ray KK, Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D, et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet. 2009;373(9677):1765-72.

Ruparelia N, Chai JT, Fisher EA, Choudhury RP. Inflammatory processes in cardiovascular disease: a route to targeted therapies. Nat Rev Cardiol. 2017;14(3):133-44.

Kounis NG, Soufras GD, Tsigkas G, Hahalis G. White blood cell counts, leukocyte ratios, and eosinophils as inflammatory markers in patients with coronary artery disease. Clin Appl Thromb Hemost. 2015;21(2):139-43.

Yang J, Zheng Y, Li C, Gao J, Meng X, Zhang K, et al. The Impact of the Stress Hyperglycemia Ratio on Short-term and Long-term Poor Prognosis in Patients With Acute Coronary Syndrome: Insight From a Large Cohort Study in Asia. Diabetes Care. 2022;45(4):947-56.

Ladeira RT, Baracioli LM, Faulin TE, Abdalla DS, Seydell TM, Maranhão RC, et al. Unrecognized diabetes and myocardial necrosis: predictors of hyperglycemia in myocardial infarction. Arq Bras Cardiol. 2013;100(5):404-11.

Cuesta-Mero PL, García-Romo LA, Villacres-López ÁD. Leukoglucemic index as a prognostic marker for complications in patients with acute myocardial infarction. Rev. Colomb. de Cardiol. 2021;28(2):119-27.

Padilla-Cueto D, Hernández-Negrín H, Ramírez-Gómez JI, Pérez-Valdivia A, Cárdenas-Sánchez AL, Alfonso-Izquierdo A. The leucoglycaemic index is a predictor of one-year all-cause mortality in Cuban patients with ST-segment elevation acute myocardial infarction. CorSalud. 2019;11(1):21-9.